An interventional study of iTind in BPH, sponsored by Medi-Tate Ltd.. Completed at 12 sites in 6 countries. Open to male participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-03.
Sponsored by Medi-Tate Ltd. (part of Olympus Corporation) · Not applicable, Interventional, and Treatment
A total of up to 200 Symptomatic BPH subjects subjects will be enrolled into the study.
Study duration will be 12 months post implantation with a follow-up visits at Year 2 and Year 3.
Primary Study Objective:
The study's primary objective is to assess the efficacy of the Medi-Tate iTind in subjects with symptomatic BPH by reduction of IPSS) (International Prostate Symptoms Score) score.
Secondary Study Objectives:
Medi-Tate Ltd. is the lead sponsor of 7 studies on the registry; none are open to participants now.
First submitted before Medi-Tate Ltd. became part of Olympus Corporation.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Subject signed prior to the performance of any study procedures.
Exclusion Criteria:
Intra-Operation Exclusion:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
ITind device implant
Device: iTind
device implanted for 5-7 days
IPSS (International Prostate Symptoms Score) Responders Rate
the Proportion (%) of Total IPSS Responders (3 points) Rate
Time frame: at Month 6 Visit
Total IPSS (International Prostate Symptoms Score) Score at
Change from Baseline to Month 6 in Total IPSS Score
Time frame: 6 months
Total IPSS(International Prostate Symptoms Score) Urinary Symptoms Score
Change from Baseline to Month 6 in Total IPSS Urinary Symptoms Score
Time frame: 6 months
Total SHIM (Sexual Health Inventory for Men ) Score
Change from Baseline to Month 6 in Total SHIM Score
Time frame: 6 months
Total ISI (Incontinence Severity Index ) Score
Change from Baseline to Month 6 in Total ISI Score
Time frame: 6 months
Total EJ-MSHQ ( Ejaculation- Male Sexual Health questionnaire) Score
Change from Baseline to Month 6 in Total EJ-MSHQ Score
Time frame: 6 months
Total Flow
Change from Baseline to Month 6 in Total Flow
Time frame: 6 months
Total residual urine
Change from Baseline to Month 6 in Total residual urine
Time frame: 6 months
Total Satisfaction Rate
Change from Baseline to Month 6 in Total Satisfaction Rate
Time frame: 6 months
IPSS QoL (Quality Of Life) score
Change from Baseline to Month 6 in IPSS QoL score
Time frame: 6 months
Recovery Success Rate
Quality of Recovery Success Rate
Time frame: 1 month
Plan to share: No
No publications or documents are linked to this record.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.